Cost-effectiveness of Recurrent Dupuytren Contracture Treatment | Zendy

Alfred P. Yoon | Zendy; Robert L Kane | Zendy; David W. Hutton | Zendy; Kevin C. Chung | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cost-effectiveness of Recurrent Dupuytren Contracture Treatment

Author(s) -

Alfred P. Yoon,

Robert L Kane,

David W. Hutton,

Kevin C. Chung

Publication year - 2020

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2020.19861

Subject(s) - medicine , contracture , quality of life (healthcare) , dupuytren's contracture , regimen , quality adjusted life year , surgery , physical therapy , cost effectiveness , risk analysis (engineering) , nursing

Key Points Question What is the most cost-effective treatment regimen for recurrent Dupuytren contracture based on disease characteristics? Findings In this economic evaluation, limited fasciectomy was a cost-effective treatment for recurrent severe (ie, >45°) Dupuytren contracture at the metacarpophalangeal joint compared with percutaneous needle aponeurotomy. In low-severity metacarpophalangeal joint and proximal interphalangeal joint contractures, percutaneous needle aponeurotomy was the only cost-effective intervention. Meaning In this study, limited fasciectomy was cost-effective for treating recurrent, severe metacarpophalangeal joint contractures, but percutaneous needle aponeurotomy was the only cost-effective treatment for recurrent low-severity metacarpophalangeal joint contractures and recurrent proximal interphalangeal joint contractures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research